- Sarepta Therapeutics (NASDAQ:SRPT) is planning to undertake a $500M common stock offering.
- The company intends to grant the underwriters a 30-day option to buy up to an additional $75M common stock.
- The company intends to use the net proceeds for clinical trials, commercialization, manufacturing, business development activities, including the potential licensing or acquisition of complementary products, technologies and entities, and other general corporate purposes.
- SRPT -6.38% to $89 after-hours
Sarepta Therapeutics falls 6% amid plans of $500M common stock offering
Recommended For You
About SRPT Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
SRPT | - | - |
Sarepta Therapeutics, Inc. |